GLTO·36322Q206·US·equity·Healthcare - Biotechnology-Activist
GLTO (DAMORA THERAPEUTICS INC) is held by 35 institutional investors as of Q1 2026. Largest holders: FMR LLC ($234.3M), Avoro Capital Advisors LLC ($98M), RA CAPITAL MANAGEMENT, L.P. ($62.1M). Net institutional sentiment: Bullish.
See how GLTO's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer